Back to Search
MICHAEL LEAHY, M.D.
M.D.
Neurology Physician
NPI: 1720050073IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
48990(MA)
Education
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
Class of 1980
Research & Publications (20)
Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: a phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
PMID 17095209·Eur J Cancer·2007
3-trial
Multicenter phase II clinical study of iodine-131-rituximab radioimmunotherapy in relapsed or refractory indolent non-Hodgkin's lymphoma.
PMID 16940276·J Clin Oncol·2006
3-trial
Purification and some characteristics of a recombinant dimeric rhizobium meliloti beta-galactosidase expressed in escherichia coli.
PMID 11339953·Enzyme Microb Technol·2001
8-other
Therapeutic potential of Mdm2 inhibition in malignant germ cell tumours.
PMID 19560254·Eur Urol·2010
8-other
Factors associated with resistance to dementia despite high Alzheimer disease pathology.
PMID 19171833·Neurology·2009
4-observational
"Cajoling" as a means of engagement in the dysphagia clinic.
PMID 19145549·Semin Speech Lang·2009
8-other
Correlates of dating violence among male and female heavy-drinking college students.
PMID 18981192·J Interpers Violence·2009
8-other
Catastrophic bleeds during end-of-life care in haematology: controversies from Australian research.
PMID 18810505·Support Care Cancer·2009
8-other
Intimate partner violence and preschoolers' explicit memory functioning.
PMID 18540770·J Fam Psychol·2008
8-other
Comparison of results of total disc replacement in postdiscectomy patients versus patients with no previous lumbar surgery.
PMID 18580740·Spine (Phila Pa 1976)·2008
4-observational
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy.
PMID 18768781·Blood·2008
3-trial
Repeat treatment with iodine-131-rituximab is safe and effective in patients with relapsed indolent B-cell non-Hodgkin's lymphoma who had previously responded to iodine-131-rituximab.
PMID 18522934·Ann Oncol·2008
4-observational
A multicenter phase 2 study of risk-adjusted salvage chemotherapy incorporating vinorelbine and gemcitabine for relapsed and refractory lymphoma.
PMID 18932253·Cancer·2008
3-trial
Judging stuttering in an unfamiliar language: the importance of closeness to the native language.
PMID 18092220·Clin Linguist Phon·2008
8-other
A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992).
PMID 18417462·Ann Oncol·2008
3-trial
Effect of cranberry juice concentrate on chemically-induced urinary bladder cancers.
PMID 18497966·Oncol Rep·2008
7-preclinical
Sub-epidermal imaging using polarized light spectroscopy for assessment of skin microcirculation.
PMID 17908201·Skin Res Technol·2007
8-other
Measurement of in vivo BCR-ABL kinase inhibition to monitor imatinib-induced target blockade and predict response in chronic myeloid leukemia.
PMID 17906206·J Clin Oncol·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 109B COUNTY RD
NORTH FALMOUTH, MA 02556 - Phone
- (508) 563-6655
Quick Facts
- NPI
- 1720050073
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 46
- Publications
- 20
Are you this provider?
Claim Your Profile